Recognition of virus infection by innate pattern recognition receptors (PRRs), including membrane-associated toll-like receptors (TLR) and cytoplasmic RIG-I-like receptors (RLR), activates cascades of signal transduction pathways leading to production of type I interferons (IFN) and proinflammatory cytokines that orchestrate the elimination of the viruses. Although it has been demonstrated that PRR-mediated innate immunity plays an essential role in defending virus from infection, it also occasionally results in overwhelming production of proinflammatory cytokines that cause severe inflammation, blood vessel leakage and tissue damage. In our efforts to identify small molecules that selectively enhance PRR-mediated antiviral, but not the detrimental inflammatory response, we discovered a compound, RO 90-7501 ('2'-(4-Aminophenyl)-[2,5'-bi-1H-benzimidazol]-5-amine), that significantly promoted both TLR3 and RLR ligand-induced IFN-beta gene expression and antiviral response, most likely via selective activation of p38 mitogen-activated protein kinase (MAPK) pathway. Our results thus imply that pharmacological modulation of PRR signal transduction pathways in favor of the induction of a beneficial antiviral response can be a novel therapeutic strategy.
RO 90-7501 Enhances TLR3 and RLR Agonist Induced Antiviral Response
Creators
Fang Guo - Drexel University
Jennifer Mead - Drexel University
Nishat Aliya - Drexel University
Lijuan Wang - Drexel University
Andrea Cuconati - Hepatitis B Foundation
Lai Wei - Peking University
Kui Li - University of Tennessee Health Science Center
Timothy M. Block - Drexel University
Ju-Tao Guo - Drexel University
Jinhong Chang - Drexel University
Publication Details
PloS one, v 7(10), pp e42583-e42583
Publisher
Public Library Science
Number of pages
9
Grant note
AI061441; AI069285 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
U01AI061441 / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
Hepatitis B Foundation
Resource Type
Journal article
Language
English
Academic Unit
Microbiology and Immunology
Web of Science ID
WOS:000309454000002
Scopus ID
2-s2.0-84867055703
Other Identifier
991019168631604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: